Patents by Inventor Sunil MAHOR

Sunil MAHOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11793869
    Abstract: The present invention is directed to improved methods of Enterovirus inactivation by formaldehyde in presence of tromethamine buffer resulting in maximum recovery of D-antigen. Subsequent adsorption of said sIPV on aluminium hydroxide provides significantly dose reduced sIPV compositions.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: October 24, 2023
    Assignee: Serum Institute Of India Pvt Ltd.
    Inventors: Rajeev Mhalasakant Dhere, Sambhaji Shankar Pisal, Jagdish Kamalaji Zade, Rajendra Narayan Sabale, Hitesh Kumar Malviya, Sunil Mahor, Chetan Vilasrao Joshi
  • Patent number: 10729780
    Abstract: The present invention provides methods for preparation of stable multivalent pneumococcal polysaccharide-protein conjugate vaccine formulations. Instant stable formulations show optimal percent adsorption for each conjugate wherein, aggregation can be prevented by employing i) Individual or separate adsorption for conjugates that otherwise show lower percent adsorption by combined adsorption ii) Histidine-Succinic acid buffer system along with shift in pH from neutral pH to acidic pH iii) a polysaccharide to protein ratio between 0.5 to about 1.4 iv) a six-bladed Rushton type turbine impeller in formulation vessels.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: August 4, 2020
    Assignee: Serum Institute of India Private Ltd.
    Inventors: Rajeev Mhalasakant Dhere, Hitesh Kumar Malviya, Swapan Kumar Jana, Sambhaji Shankar Pisal, Asha Dinesh Mallya, Sunil Mahor, Manish Maheshkumar Gautam, Chetan Vilas Joshi, Venkata Vamsi Krishna Malepati, Prashant Shivaji Jadhav
  • Publication number: 20200085940
    Abstract: The present invention is directed to improved methods of Enterovirus inactivation by formaldehyde in presence of tromethamine buffer resulting in maximum recovery of D-antigen. Subsequent adsorption of said sIPV on aluminium hydroxide provides significantly dose reduced sIPV compositions.
    Type: Application
    Filed: October 10, 2019
    Publication date: March 19, 2020
    Inventors: Rajeev Mhalasakant Dhere, Sambhaji Shankar PISAL, Jagdish Kamalaji ZADE, Rajendra Narayan SABLE, Hitesh Kumar MALVIYA, Sunil MAHOR, Chetan Vilasrao JOSHI
  • Publication number: 20180161445
    Abstract: The present invention provides methods for preparation of stable multivalent pneumococcal polysaccharide-protein conjugate vaccine formulations. Instant stable formulations show optimal percent adsorption for each conjugate wherein, aggregation can be prevented by employing i) Individual or separate adsorption for conjugates that otherwise show lower percent adsorption by combined adsorption ii) Histidine-Succinic acid buffer system along with shift in pH from neutral pH to acidic pH iii) a polysaccharide to protein ratio between 0.5 to about 1.4 iv) a six-bladed Rushton type turbine impeller in formulation vessels.
    Type: Application
    Filed: June 3, 2016
    Publication date: June 14, 2018
    Applicant: Serum Institute of India Privated Ltd.
    Inventors: Rajeev Mhalasakant DHERE, Hitesh Kumar MALVIYA, Swapan Kumar JANA, Sambhaji Shankar PISAL, Asha Dinesh MALLYA, Sunil MAHOR, Manish Maheshkumar GAUTAM, Chetan Vilas JOSHI, Venkata Vamsi Krishna MALEPATI, Prashant Shivaji JADHAV